Although primarily a lung disease, extra-pulmonary tuberculosis (TB) can affect any organ or
system. Of these, cardiovascular complications associated with disease or drug toxicity …

Introduction Cancer is a major cause of death among people who experience tuberculosis
(TB), but little is known about its timing and incidence following TB treatment. Our primary …

TB affects around 10.6 million people each year and there are now around 155 million TB
survivors. TB and its treatments can lead to permanently impaired health and wellbeing. In …

A considerable epidemiological and pathogenetic overlap exists between tuberculosis (TB)
and cardiovascular diseases (CVD). The objective of this study was to establish the …

Background: Conflicting results exist regarding the risk of ischemic stroke in tuberculosis
survivors. We aimed to estimate the risk of ischemic stroke using a nationwide population …

Background Despite data suggesting elevated morbidity and mortality among people who
have survived tuberculosis disease, the impact of respiratory tuberculosis on healthcare …

• Most patients with TB disease should be initiated on a regimen of isoniazid, rifampin,
pyrazinamide and ethambutol until results of genotypic or phenotypic drug susceptibility are …

Background The global burden of tuberculosis (TB) and cardiovascular disease (CVD) is
overt, and the prevalence of this double burden disease remains steadily rising, particularly …

Background Tuberculosis (TB) has been linked to an increased risk of atherosclerotic
cardiovascular disease (ASCVD). We assessed whether latent TB infection (LTBI) is …

Background Limited evidence suggests elevated risks of cardiovascular disease (CVD)
among people diagnosed with tuberculosis (TB) disease, though studies have not adjusted …